Good Morning. Welcome to The Wire’s daily news roundup. Each day, our staff gathers the top China business, finance, and economics headlines from a selection of the world’s leading news organizations.
Paid subscribers can have this list emailed directly to their inboxes every day. Subscribe here, and then send us an email at contact@thewirechina.com to opt in for the Daily Roundup email.
The Wall Street Journal
Brazil to Resume Trials of China’s Sinovac Coronavirus Vaccine — Researchers had criticized the suspension by Brazilian health authority Anvisa.China’s Health-Care Listings Break Records — More than 60 Chinese health-care companies have raised a total $16.3 billion from IPOs and secondary listings this year.Alibaba Sets ‘Singles Day’ Sales Record — Chinese technology company, under regulatory shadow, reaps $75.1 billion in sales in annual shopping event.Hong Kong Security Law: How Beijing Is Cracking Down — Hong Kong’s Beijing-backed government
Subscribe or login to read the rest.
Subscribers get full access to:
- Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
- A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
- A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our
Subscriptions page for details.
